[link removed]
[link removed] [link removed]
View web version ([link removed])
[link removed]
Dr. Elizabeth Nabel's stock sales have infuriated a number of Brigham and Women’s employees
The head of Brigham and Women’s Hospital sold nearly $2 million worth of Moderna stock in May, just as the institution she led was preparing cost-cutting due to COVID-19, bringing her total earnings from the biotech company to $8.5 million this year.
Nabel resigned from the Cambridge biotech’s board of directors Thursday amid concerns that her position there might conflict with the hospital’s role in a large study of the vaccine.
Read the full story. ([link removed])
Brigham president resigns from Moderna board after conflict of interest questions raised ([link removed])
------------------------------------------------------------
We have lots of e-mail newsletters on a variety of topics, including news, politics, business, sports, lifestyle, and more. They're free, and it's easy to subscribe. Here's a complete list. ([link removed])
------------------------------------------------------------
[link removed]
[link removed] [link removed]
============================================================
** Like us ([link removed])
** Follow us ([link removed])
You received this message because you signed up for Breaking News Alerts.
Copyright © 2020 The Boston Globe, All rights reserved.
Our mailing address is:
The Boston Globe
1 Exchange Place Suite 201
Boston, MA 02109-2132
USA
** unsubscribe from this list ([link removed])
** Manage Your Account ([link removed])
| ** Terms of Service ([link removed])
| ** Privacy Policy ([link removed])
| ** Help Center ([link removed])
| ** Advertise (mailto:
[email protected]?subject=Advertising+in+BostonGlobe.com)